LLY

1,102.5

+0.95%↑

JNJ

207.31

+0.22%↑

ABBV

227.86

-1.85%↓

UNH

330.44

+1.66%↑

AZN

93.65

+0.84%↑

LLY

1,102.5

+0.95%↑

JNJ

207.31

+0.22%↑

ABBV

227.86

-1.85%↓

UNH

330.44

+1.66%↑

AZN

93.65

+0.84%↑

LLY

1,102.5

+0.95%↑

JNJ

207.31

+0.22%↑

ABBV

227.86

-1.85%↓

UNH

330.44

+1.66%↑

AZN

93.65

+0.84%↑

LLY

1,102.5

+0.95%↑

JNJ

207.31

+0.22%↑

ABBV

227.86

-1.85%↓

UNH

330.44

+1.66%↑

AZN

93.65

+0.84%↑

LLY

1,102.5

+0.95%↑

JNJ

207.31

+0.22%↑

ABBV

227.86

-1.85%↓

UNH

330.44

+1.66%↑

AZN

93.65

+0.84%↑

Search

CareDx Inc

Abierto

SectorSanidad

17.73 -1.28

Resumen

Variación precio

24h

Actual

Mínimo

17.41

Máximo

17.97

Métricas clave

By Trading Economics

Ingresos

10M

1.7M

Ventas

13M

100M

P/B

Media del Sector

12.117

106.172

Margen de beneficios

1.674

Empleados

644

EBITDA

11M

6.8M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+33.63% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

39M

826M

Apertura anterior

19.01

Cierre anterior

17.73

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

167 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

CareDx Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

25 nov 2025, 16:56 UTC

Ganancias
Principales Movimientos del Mercado

Alimentation Couche-Tard Shares Rise as 2Q Same-Store Sales Support Profit Growth

25 nov 2025, 23:47 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

25 nov 2025, 23:47 UTC

Charlas de Mercado

Nikkei May Rise After Stock Gains on Wall Street -- Market Talk

25 nov 2025, 22:39 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

25 nov 2025, 22:39 UTC

Charlas de Mercado

Vault Accelerates Exposure to Spot Gold Prices by Six Months -- Market Talk

25 nov 2025, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

25 nov 2025, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

25 nov 2025, 21:38 UTC

Ganancias

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25 nov 2025, 21:31 UTC

Charlas de Mercado

F&P Healthcare's Share Price Jumps on Profit Guidance Upgrade -- Market Talk

25 nov 2025, 21:27 UTC

Ganancias

These Stocks Moved the Most Today: Nvidia, AMD, Alphabet, Abercrombie, Kohl's, Novo Nordisk, Symbotic, and More -- Barrons.com

25 nov 2025, 21:20 UTC

Ganancias

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25 nov 2025, 21:18 UTC

Ganancias

NIO Stock Drops as EV Maker Posts Narrower Loss -- Barrons.com

25 nov 2025, 21:15 UTC

Ganancias

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25 nov 2025, 20:16 UTC

Charlas de Mercado

U.S. Natural Gas Falls as December Contract Expires -- Market Talk

25 nov 2025, 18:42 UTC

Charlas de Mercado

USDA Backs Mexican Retail Expo to Raise Agricultural Exports -- Market Talk

25 nov 2025, 18:25 UTC

Adquisiciones, fusiones, absorciones

S&P Global Completes $1.8 Billion Acquisition Of With Intelligence, Strengthening Its Position As A Leader In Private Markets Data & Analytics >SPGI

25 nov 2025, 17:30 UTC

Charlas de Mercado

Mexico Posts Record Foreign Direct Investment for Jan-Sep -- Market Talk

25 nov 2025, 17:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

25 nov 2025, 17:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

25 nov 2025, 16:33 UTC

Adquisiciones, fusiones, absorciones

Eni: Financial Details Weren't Disclosed

25 nov 2025, 16:33 UTC

Adquisiciones, fusiones, absorciones

Eni: Block OFF-5 Covers an Area of About 17,000 Km Sq. in Water Depths

25 nov 2025, 16:32 UTC

Adquisiciones, fusiones, absorciones

Eni: Agreement to Become Effective After Approval of Uruguayan Authorities

25 nov 2025, 16:31 UTC

Adquisiciones, fusiones, absorciones

Eni: Acquisition Is for a 50% Share, Operatorship in Exploration Block OFF-5

25 nov 2025, 16:30 UTC

Adquisiciones, fusiones, absorciones

Eni Acquires From YPF Shares in the Exploration Block OFF-5 Offshore Uruguay

25 nov 2025, 16:23 UTC

Ganancias

This Robotics Stock Soars 40% on Earnings. Here's Why. -- Barrons.com

25 nov 2025, 16:12 UTC

Charlas de Mercado

Euro Expected to Rise to $1.25 in 2026: Deutsche Bank -- Market Talk

25 nov 2025, 16:11 UTC

Charlas de Mercado

Dollar Could Take One Final Leg Lower in Early 2026 -- Market Talk

25 nov 2025, 16:10 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

25 nov 2025, 16:10 UTC

Charlas de Mercado

Sterling Could Briefly Rise After Budget -- Market Talk

25 nov 2025, 16:10 UTC

Charlas de Mercado

Oil Extends Losses on Ukraine-Russia Peace Deal Hopes -- Market Talk

Comparación entre iguales

Cambio de precio

CareDx Inc previsión

Precio Objetivo

By TipRanks

33.63% repunte

Estimación a 12 Meses

Media 24 USD  33.63%

Máximo 26 USD

Mínimo 22 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CareDx Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

14.77 / 18.49Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

167 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat